Table 3.
Correlation of HBV infection status and clinical characteristics of patients with ENKTL (n=407).
|
Variable |
HBsAg-(-)/anti-HBc-(-) | HBsAg-(+)/anti-HBc-(+) | HBsAg-(-)/anti-HBc-(+) |
p |
|
|---|---|---|---|---|---|
| Age | >60 | 27(50.0%) | 5(9.3%) | 22(40.7%) | 0.21 |
| ≤60 | 209(59.2%) | 42(11.9%) | 102(28.9%) | ||
| Gender | male | 152(55.7%) | 35(12.8%) | 86(31.5%) | 0.33 |
| Female | 84(62.7%) | 12(9.0%) | 38(28.4%) | ||
| ECOG score | 0-1 | 226(57.2%) | 45(11.4%) | 124(31.4) | 0.067 |
| ≥2 | 10(83.3%) | 2(16.7%) | 0(0.0%) | ||
| B symptoms | Yes | 121(57.1) | 28(13.2%) | 63(29.7) | 0.549 |
| No | 115(59.0%) | 19(9.7%) | 61(31.3%) | ||
| Ann Arbor stage | Ⅰ-Ⅱ | 184(55.4%) | 38(11.4%) | 110(33.1%) | 0.044 |
| Ⅲ-Ⅳ | 52(69.3%) | 9(12.0%) | 14(18.7%) | ||
| ALT elevation | Yes | 55(50.9%) | 20(18.5%) | 33(30.6%) | 0.024 |
| No | 181(60.5%) | 27(9.0%) | 91(30.4%) | ||
| AST elevation | Yes | 39(54.9%) | 16(22.5%) | 16(22.5%) | 0.004 |
| No | 197(58.6%) | 31(9.2%) | 108(32.1%) | ||
| LDH elevation | Yes | 76(56.7) | 19(14.2%) | 39(29.1%) | 0.503 |
| No | 160(58.6%) | 28(10.3%) | 85(31.1%) | ||
| IPI | 0-1 | 183(56.0%) | 37(11.3%) | 107(32.7%) | 0.133 |
| ≥2 | 53(66.3%) | 10(12.5%) | 17(21.3%) | ||